Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01544140 · ClinicalTrials.gov registry record · Phase 1
Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With Vandetanib
A Phase 1 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT01544140 is a Phase 1 study that has completed, run by Sanofi. The registered enrollment target is 16 participants.
The verdict
NCT01544140, a Phase 1 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study in healthy volunteers is to assess the Pharmacokinetics (PK) of Midazolam administered alone and in combination with Vandetanib.
Interventions
- DRUG Midazolam
- DRUG vandetanib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01544140
The ClinicalTrials.gov registry entry for NCT01544140 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Midazolam is the first listed.
NCT01544140 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01544140 about?
NCT01544140 is a clinical study titled "Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With Vandetanib". The purpose of this study in healthy volunteers is to assess the Pharmacokinetics (PK) of Midazolam administered alone and in combination with Vandetanib.
What is the current status of trial NCT01544140?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2012-04. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01544140?
The interventions under investigation include: Midazolam (DRUG), vandetanib (DRUG).
Who is sponsoring clinical trial NCT01544140?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.